For: | Fan Y, Zheng S, Xu ZF, Ding JY. Apoptosis induction with polo-like kinase-1 antisense phosph-orothioate oligodeoxynucleotide of colon cancer cell line SW480. World J Gastroenterol 2005; 11(29): 4596-4599 [PMID: 16052696 DOI: 10.3748/wjg.v11.i29.4596] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i29/4596.htm |
Number | Citing Articles |
1 |
Yu Fan, You-Li Zhang, Ying Wu, Wei Zhang, Yin-Huan Wang, Zhao-Ming Cheng, Hua Li. Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells. World Journal of Gastroenterology 2008; 14(3): 428-434 doi: 10.3748/wjg.14.428
|
2 |
Wen-Jing Xu, Shuang Zhang, Yang Yang, Na Zhang, Wei Wang, Sheng-Yong Liu, Hong-Wei Tian, Lei Dai, Qian Xie, Xia Zhao, Yu-Quan Wei, Hong-Xin Deng. Efficient Inhibition of Human Colorectal Carcinoma Growth by RNA Interference Targeting Polo-Like Kinase 1 In Vitro and In Vivo. Cancer Biotherapy and Radiopharmaceuticals 2011; 26(4): 427 doi: 10.1089/cbr.2010.0922
|
3 |
Ion Cristóbal, Federico Rojo, Juan Madoz-Gúrpide, Jesús García-Foncillas. Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications. Molecular and Cellular Biology 2016; 36(12): 1734 doi: 10.1128/MCB.00130-16
|
4 |
Galina A. Gusarova, I-Ching Wang, Michael L. Major, Vladimir V. Kalinichenko, Timothy Ackerson, Vladimir Petrovic, Robert H. Costa. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. Journal of Clinical Investigation 2007; 117(1): 99 doi: 10.1172/JCI27527
|
5 |
Shiv Kumar, Garima Sharma, Chiranjib Chakraborty, Ashish Ranjan Sharma, Jaebong Kim. Regulatory functional territory of PLK-1 and their substrates beyond mitosis. Oncotarget 2017; 8(23): 37942 doi: 10.18632/oncotarget.16290
|
6 |
Michel V. Hadjihannas, Martina Brückner, Boris Jerchow, Walter Birchmeier, Wolfgang Dietmaier, Jürgen Behrens. Aberrant Wnt/β-catenin signaling can induce chromosomal instability in colon cancer. Proceedings of the National Academy of Sciences 2006; 103(28): 10747 doi: 10.1073/pnas.0604206103
|
7 |
Yan‐Bin Feng, De‐Chen Lin, Zhi‐Zhou Shi, Xiao‐Chun Wang, Xiao‐Ming Shen, Yu Zhang, Xiao‐Li Du, Man‐Li Luo, Xin Xu, Ya‐Ling Han, Yan Cai, Zi‐Qiang Zhang, Qi‐Min Zhan, Ming‐Rong Wang. Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma. International Journal of Cancer 2009; 124(3): 578 doi: 10.1002/ijc.23990
|
8 |
Masahisa Kudo, Nicole Zalles, Rosario Distefano, Giovanni Nigita, Dario Veneziano, Pierluigi Gasparini, Carlo M. Croce. Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells. Cell Death & Differentiation 2022; 29(2): 407 doi: 10.1038/s41418-021-00864-2
|
9 |
Nirmalya Dasgupta, Bhupesh Kumar Thakur, Atri Ta, Sayan Das, George Banik, Santasabuj Das. Polo-like kinase 1 expression is suppressed by CCAAT/enhancer-binding protein α to mediate colon carcinoma cell differentiation and apoptosis. Biochimica et Biophysica Acta (BBA) - General Subjects 2017; 1861(7): 1777 doi: 10.1016/j.bbagen.2017.03.015
|